
Professor Margaret Ilomuanya is the principal investigator of the MEDAFRICA GMP Laboratory and a professor of pharmaceutics and pharmaceutical technology at the University of Lagos, Nigeria. She has built a distinguished career in research, teaching, mentorship, translational science, and academic leadership.
Her expertise spans novel drug delivery systems and the development of topical dosage forms, including creams, hydrogels, organogels, and electrospun fibres. Her research sits at the intersection of drug delivery, biomaterials, and global health, with a strong focus on developing innovative solutions to critical healthcare challenges, particularly in low- and middle-income countries.
Ilomuanya obtained her Bachelor of Pharmacy (B.Pharm) degree and PhD in Pharmaceutics and Pharmaceutical Technology from the University of Lagos. Her quest for knowledge took her beyond Nigeria, where she undertook a predoctoral research fellowship at the University of Nottingham in 2011 and a research fellowship at the University of Pennsylvania in 2012.
An innovative scholar, Ilomuanya has made significant contributions to drug delivery research, particularly in HIV microbicide development, non-hormonal contraception, cosmeceuticals, and wound-healing applications. She also integrates artificial intelligence tools into drug formulation and development to optimise research processes and outcomes.
Beyond laboratory research, she is deeply committed to public health engagement. She provides health information to healthcare workers and participates in medical outreach programmes serving underserved communities across Africa. Her career therefore reflects a balance of scientific innovation, translational research, community engagement, and academic leadership.
Ilomuanya has authored and co-authored more than 140 scholarly publications in peer-reviewed international journals, books, and conference proceedings. Her research has attracted support from reputable international funders, including the Science for Africa Foundation and the Bill & Melinda Gates Foundation, highlighting the relevance of her work to global health priorities. She has also collaborated with leading institutions worldwide.
She was a JEIVEN Fellow at the Centre for Biomedical Research, Population Council, New York, in 2020. She is also a Fellow of the Pharmaceutical Society of Nigeria, among other professional distinctions, and has received both national and international research grants.
Beyond her academic and research accomplishments, Prof. Ilomuanya is deeply committed to mentorship, capacity building, and community development. She is widely regarded as a bridge between academia and industry, research and practice, and local healthcare challenges and global solutions. Through pharmaceutical innovation, collaboration, mentorship, and translational science, she continues to contribute to improved health outcomes and sustainable impact in Nigeria and beyond.





